Koch et al., 2021, looking for novel treatment strategies to improve the clinical outcome in patients with Burkitt’s lymphoma (a highly aggressive form of B-cell NHL), demonstrate that the combinational treatment with the Smac mimetic BV6 and TRAIL triggers necroptosis [71]. This evidence concerns the gene TNFSF10 and B-cell non-Hodgkin lymphoma.